Lorenz Trümper

1994–2025 年に発表

77
論文数
20,355
被引用数
62
h 指数
75
i10 指数

被引用数

Lorenz Trümper の年別被引用数1974 年: 被引用 1 件1979 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 7 件1996 年: 被引用 7 件1997 年: 被引用 6 件1998 年: 被引用 7 件1999 年: 被引用 5 件2000 年: 被引用 12 件2001 年: 被引用 10 件2002 年: 被引用 26 件2003 年: 被引用 31 件2004 年: 被引用 22 件2005 年: 被引用 40 件2006 年: 被引用 50 件2007 年: 被引用 71 件2008 年: 被引用 130 件2009 年: 被引用 128 件2010 年: 被引用 154 件2011 年: 被引用 205 件2012 年: 被引用 200 件2013 年: 被引用 153 件2014 年: 被引用 173 件2015 年: 被引用 164 件2016 年: 被引用 153 件2017 年: 被引用 146 件2018 年: 被引用 147 件2019 年: 被引用 581 件2020 年: 被引用 658 件2021 年: 被引用 633 件2022 年: 被引用 495 件2023 年: 被引用 322 件2024 年: 被引用 542 件2025 年: 被引用 209 件2026 年: 被引用 5 件1975〜1978 年は被引用が無いため表示していません1980〜1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,885 件、この内訳の 22.6%ドイツ: 引用元論文 857 件、この内訳の 10.3%中国: 引用元論文 621 件、この内訳の 7.4%イギリス: 引用元論文 495 件、この内訳の 5.9%イタリア: 引用元論文 488 件、この内訳の 5.8%フランス: 引用元論文 429 件、この内訳の 5.1%スペイン: 引用元論文 347 件、この内訳の 4.2%カナダ: 引用元論文 341 件、この内訳の 4.1%スイス: 引用元論文 275 件、この内訳の 3.3%オランダ: 引用元論文 235 件、この内訳の 2.8%日本: 引用元論文 213 件、この内訳の 2.5%オーストラリア: 引用元論文 189 件、この内訳の 2.3%
0%22.6%その他 23.7%

分野

  • Medicine70.6%
  • Biochemistry, Genetics and Molecular Biology23%
  • Immunology and Microbiology3.7%
  • Neuroscience1.6%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • Materials Science0.2%
  • その他0.7%

トピック

  • Lymphoma Diagnosis and Treatment17.3%
  • Chronic Lymphocytic Leukemia Research6%
  • CAR-T cell therapy research5%
  • Viral-associated cancers and disorders4.4%
  • CNS Lymphoma Diagnosis and Treatment4.2%
  • Immune Cell Function and Interaction2.5%
  • その他60.6%

共著者

全論文

検索で開く
  1. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Reiner Siebert, Andreas Rosenwald, Aaron R. Thorner, Matthew Meyerson, Todd R. Golub, Rameen Beroukhim, Gerald Wulf, German Ott, Scott J. Rodig, Stefano Monti, Donna Neuberg, Markus Loeffler, Michael Pfreundschuh, Lorenz Trümper, Gad Getz, Margaret A. Shipp - Nature Medicine 2018 被引用: 1,972

  2. The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2021 被引用: 262

  3. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lorenz Trümper, David M. Aboulafia, Ranjana H. Advani, Önder Alpdoğan, Kiyoshi Ando, Luca Arcaini, Luca Baldini, Naresh Bellam, Nancy L. Bartlett, David Belada, Dina Ben Yehuda, Fabio Benedetti, Peter Borchman, Dominique Bordessoule, Pauline Brice, Javier Briones, Dolores Caballero, Angelo Michele Carella, Hung Chang, June Weon Cheong, Seok‐Goo Cho, Ilseung Choi, Sylvain Choquet, Andrei Coliţă, Angela Giovanna Congui, Francesco d’Amore, Nam H. Dang, Kelly Davison, Sophie de Guibert, Peter de Nully Brown, Vincent Delwail, Judit Demeter, Francesco Di Raimondo, Young Rok, Eva Domingo, Michael G. Douvas, Martin Dreyling, Thomas Ernst, Michelle A. Fanale, Keith Fay, Tatyana Feldman, Silvia Ferrero, Ian W. Flinn, Andres Forero‐Torres, Christopher P. Fox, Jonathan W. Friedberg, Noriko Fukuhara, José A. García‐Marco, Jorge Gayoso Cruz, José Codina, Rémy Gressin, Andrew Grigg, Ronit Gurion, Jacob Haaber Christensen, Corinne Haïoun, Roman Hájek, Mathias Hänel, Kiyohiko Hatake, Robert Hensen, Netanel A. Horowitz, Steven M. Horwitz, Andreas Hüttmann, Árpád Illés, Tim Illidge, Kenichi Ishizawa, Miguel Islas‐Ohlmayer, Eric D. Jacobsen, Murali Janakiram, Wojciech Jurczak, Mark Kaminski ほか 69 名 - The Lancet 2018 被引用: 726

  4. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2006 被引用: 2,085

  5. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2011 被引用: 811

  6. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2008 被引用: 1,135

  7. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christiane Falge, Lothar Kanz, Stephan Kremers, Andreas Burchert, Michael Kneba, Frank Stegelmann, Claus-Henning Köhne, H. W. Lindemann, Cornelius F. Waller, M. Pfreundschuh, Karsten Spiekermann, Wolfgang E. Berdel, Lothar Müller, Matthias Edinger, Jiřı́ Mayer, Dietrich W. Beelen, Martin Bentz, Hartmut Link, Bernd Hertenstein, Roland J. Fuchs, Martin Wernli, Frank Schlegel, Rudolf Schlag, Maike de Wit, Lorenz Trümper, Holger Hebart, Markus Hahn, Jörg Thomalla, Christof Scheid, Philippe Schafhausen, Walter Verbeek, Michael J. Eckart, W. Gaßmann, Antonio Pezzutto, Michael Schenk, Peter Brossart, Thomas Geer, Stephan Bildat, E. Schäfer, Andreas Hochhaus, Joerg Hasford - Leukemia 2017 被引用: 339

  8. The genomic and transcriptional landscape of primary central nervous system lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lorenz Trümper, Ioannis Anagnostopoulos, Dido Lenze, Ralf Küppers, Michael Hummel, Clemens A. Schmitt, Otmar D. Wiestler, Stephan Wolf, Andreas Unterberg, Roland Eils, Christel Herold‐Mende, Benedikt Brors, Coordination (C1), Reiner Siebert, Susanne Wagner, Andrea Haake, Julia Richter, Gesine Richter, Roland Eils, Chris Lawerenz, Jürgen Eils, Jules N. A. Kerssemakers, Christina Jaeger-Schmidt, Ingrid Scholz, Anke Bergmann, Christoph Borst, Friederike Braulke, Birgit Burkhardt, Alexander Claviez, Martin Dreyling, Sonja Eberth, Hermann Einsele, Norbert Frickhofen, Siegfried Haas, Martin‐Leo Hansmann, Dennis Karsch, Nicole Klepl, Michael Kneba, Jasmin Lisfeld, Luisa Mantovani‐Löffler, Marius Rohde, German Ott, Christina Stadler, Peter Staib, Stephan Stilgenbauer, Thorsten Zenz, Normal Cells (WPN), Martin‐Leo Hansmann, Dieter Kube, Pathology and Analyte Preparation (WP2-3), Siegfried Haas, Wolfgang Hiddemann, Ulrike Kostezka, Peter Möller, Andreas Rosenwald, German Ott, Monika Szczepanowski, Sequencing and genomics (WP4-7), Ole Ammerpohl, Sietse Aukema, Vera Binder, Arndt Borkhardt, Andrea Haake, Jessica I. Hoell, Ellen Leich, Peter Lichter, Cristina López, Inga Nagel, Jordan Pischimariov, Bernhard Radlwimmer ほか 27 名 - Nature Communications 2022 被引用: 140

  9. Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2010 被引用: 921

  10. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

    著者: , , , , , , , , , - Blood 2010 被引用: 592

  11. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3

    著者: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 被引用: 359

  12. NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity

    著者: , , , , , , , , , , , , , , , , , , , , - Circulation 2005 被引用: 488

  13. Randomized Phase III Study of Alisertib or Investigator’s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 150

  14. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Hummel, Jan O. Korbel, Chris Lawerenz, Dido Lenze, Bernhard Radlwimmer, Julia Richter, Philip Rosenstiel, Andreas Rosenwald, Markus B. Schilhabel, Harald Stein, Stephan Stilgenbauer, Peter F. Stadler, Monika Szczepanowski, Marc A. Weniger, Marc Zapatka, Roland Eils, Peter Lichter, Markus Loeffler, Peter Mӧller, Lorenz Trümper, Wolfgang Hiddemann, Susanne Wagner, Gesine Richter, Jürgen Eils, Jules N. A. Kerssemakers, Christina Jaeger-Schmidt, Ingrid Scholz, Christoph Borst, Friederike Braulke, Martin Dreyling, Sonja Eberth, Hermann Einsele, Norbert Frickhofen, Siegfried Haas, Dennis Karsch, Nicole Klepl, Michael Kneba, Jasmin Lisfeld, Luisa Mantovani‐Löffler, German Ott, Christina Stadler, Peter Staib, Thorsten Zenz, Dieter Kube, Ulrike Kostezka, Vera Binder, Ellen Leich, Inga Nagel, Jordan Pischimariov, Stefan Schreiber, Inga Vater, Lydia Hopp, David Langenberger, Maciej Rosołowski, Steve Hoffmann, Ralf Küppers, Birgit Burkhardt, Matthias Schlesner, Reiner Siebert - Nature Communications 2019 被引用: 154

  15. A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rainer Spang, Markus Loeffler, Lorenz Trümper, Harald Stein, Reiner Siebert - New England Journal of Medicine 2006 被引用: 1,009

  16. Microglia promote colonization of brain tissue by breast cancer cells in a Wnt‐dependent way

    著者: , , , , , , , , , , , , , , , , - Glia 2010 被引用: 244

  17. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lorenz Trümper, Inga Vater, Swen Weßendorf, Wolfgang Hiddemann, Reiner Siebert - Blood 2014 被引用: 228

  18. Clinical Impact of the Cell-of-Origin Classification and the MYC / BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 219

  19. DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennis Karsch, Hinrik H D Kerstens, Wolfgang Hiddemann, Markus Kreuz, Chris Lawerenz, Dido Lenze, Markus Loeffler, Cristina López, Roderick A.F. MacLeod, Joost H.A. Martens, Marta Kulis, José I. Martín‐Subero, Peter Mӧller, Inga Nagel, Simone Picelli, Inga Vater, Marius Rohde, Philip Rosenstiel, Maciej Rosołowski, Robert B. Russell, Markus B. Schilhabel, Matthias Schlesner, Peter F. Stadler, Monika Szczepanowski, Lorenz Trümper, Hendrik G. Stunnenberg, Ralf Küppers, Ole Ammerpohl, Peter Lichter, Reiner Siebert, Steve Hoffmann, Bernhard Radlwimmer - Nature Genetics 2015 被引用: 150

  20. Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Volker Hovestadt, Bingding Huang, Michael Hummel, Christina Jäger-Schmidt, Jules N. A. Kerssemakers, Jan O. Korbel, Dieter Kube, Chris Lawerenz, Dido Lenze, Joost H.A. Martens, German Ott, Bernhard Radlwimmer, Eva Reisinger, Julia Richter, Daniel Rico, Philip Rosenstiel, Andreas Rosenwald, M. Schillhabel, Stephan Stilgenbauer, Peter F. Stadler, José I. Martín‐Subero, Monika Szczepanowski, Gregor Warsow, Marc A. Weniger, Marc Zapatka, Alfonso Valencia, Hendrik G. Stunnenberg, Peter Lichter, Peter Mӧller, Markus Loeffler, Roland Eils, Wolfgang Hiddemann, Steve Hoffmann, Lorenz Trümper, Ralf Küppers, Matthias Schlesner, Reiner Siebert - Leukemia 2021 被引用: 59

  21. Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2020 被引用: 91

  22. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

    著者: , , , , , , , , , , , , , , , , , , - Blood 2007 被引用: 789

  23. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines

    著者: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 被引用: 366

  24. MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Dreyling, Sonja Eberth, Lorenz Trümper, Dieter Kube, Christina Stadler, Hermann Einsele, Norbert Frickhofen, Martin‐Leo Hansmann, Dennis Karsch, Michael Kneba, Luisa Mantovani‐Löffler, Peter Staib, Stephan Stilgenbauer, German Ott, Ralf Küppers, Marc A. Weniger, Michael Hummel, Dido Lenze, Monika Szczepanowski, Wolfgang Hiddemann, Ulrike Kostezka, Peter Möller, Andreas Rosenwald, Ellen Leich, Jordan Pischimariov, Vera Binder, Arndt Borkhardt, Kebria Hezaveh, Jessica I. Hoell, Philip Rosenstiel, Markus B. Schilhabel, Stefan Schreiber, Stephan H. Bernhart, Gero Doose, Steve Hoffmann, Helene Kretzmer, David Langenberger, Hans Binder, Lydia Hopp, Markus Kreuz, Markus Loeffler, Maciej Rosołowski, Jan O. Korbel, Stefanie Sungalee, Peter F. Stadler, Thorsten Zenz, Roland Eils, Matthias Schlesner, Axel Diernfellner, Michael Brunner - Nature Communications 2016 被引用: 125